My doctoral research investigates how a small RNA molecule, microRNA-192, guides human stem cells toward a pancreatic beta cell fate. Using a CRISPR-Cas9-engineered, inducible miRNA system, I aim to improve […] Read More
With a goal of advancing regenerative medicine approaches to treating diabetes, ISCRM fellow Mark Andrade will explore the feasibility of activating Sonic Hedghog and/or Wnt signaling in pancreatic beta-cells “after” […] Read More